(Yicai) Oct. 27 -- Gilead Sciences has benefited from China's accelerated regulatory reforms in granting market access for innovative drugs, with the country's pilot zones enabling near-simultaneous ...

South Africa has become the first African country — and our medicines regulator the third worldwide — to register the revolutionary twice-a-year anti-HIV jab, lenacapavir (LEN). The shot could bring ...

Themed "Science in Future", the 2025 World Laureates Forum gathered about 150 scientists from more than 10 countries, ...

Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the company will participate in fireside ...

A quarter-point rate cut is all but certain at this week’s Federal Open Market Committee meeting. And we’ll see earnings ...

The company will move its development center in Beersheva to new 3,000 square meter offices in the Gav-Yam Park ...

The market enters the fourth full week of the government shutdown with international trade and domestic rates in focus.

The Fed’s next move comes amid increasing fears of weakness in the labor market; lower borrowing costs could help spur business activity and create more jobs. However, the rate cut decision arrives as ...

Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.